Skip to content

Psychedelic-assisted therapy for substance use disorders: Between urgency and uncertainty.

Am J Addict March 1, 2026 DOI: 10.1111/ajad.70128 via PubMed

Summary

AI-generated from the abstract

The text discusses the tension between the urgent need for effective treatments for substance use disorders and the uncertainty surrounding the efficacy and safety of psychedelic-assisted therapy. It highlights the potential benefits of using psychedelics in therapeutic settings while emphasizing the lack of conclusive evidence and the need for rigorous research to address gaps in knowledge. The authors call for a balanced approach that acknowledges both the promise and the risks, urging careful consideration of ethical, clinical, and regulatory challenges before widespread implementation.

Study at a glance

Characteristics Theoretical or philosophical paper Peer reviewed
Key finding Psychedelic-assisted therapy for substance use disorders presents both promise and uncertainty, requiring balanced, evidence-based approaches.

Abstract

Psychedelic-assisted therapy for substance use disorders: Between urgency and uncertainty.

Comments

No comments yet.

Log in to comment